Zobrazeno 1 - 10
of 339
pro vyhledávání: ''
Autor:
Diana Bell, Ahmed S. Abdelmeguid, Frederico O. Gleber-Netto, Ehab Y. Hanna, Curtis R. Pickering, Dianna B. Roberts, Yoko Takahashi, Jeffrey N. Myers, Tongxin Xie
Publikováno v:
Oral Oncology. 97:56-61
Objectives Sinonasal undifferentiated carcinoma (SNUC) is a rare, highly aggressive cancer. Despite aggressive multimodal therapy, its prognosis remains poor. Because of its locally advanced nature and high propensity for distant metastasis, we frequ
Publikováno v:
Oral Oncol
Objective To characterize temporal trends in treatment patterns for oropharyngeal carcinoma, and to evaluate the emerging role of surgical therapy in the era of transoral robotic surgery (TORS). Methods Patients with oropharynx cancer between 2004 an
Autor:
Luke H. DeGraaff, Moni A. Kuriakose, William D. Duncan, Mary E. Platek, Anurag K. Singh, Vishal Gupta, Chong Wang, A. Platek, Kimberly E. Wooten, Austin J. Iovoli, Hassan Arshad, Wesley L. Hicks
Publikováno v:
Oral Oncology. 86:273-277
Objectives To examine the utility of computed tomography (CT) imaging during routine surveillance for the detection of recurrent head and neck squamous cell carcinoma (HNSCC). Materials/methods Clinical characteristics of HNSCC patients treated betwe
Autor:
Jessica Ley, Douglas Adkins, Ronald J. Maggiore, Jingxia Liu, Peter Oppelt, Kevin Palka, Francis P. Worden
Publikováno v:
Oral oncology. 114
Objectives We previously reported that palbociclib, a selective CDK4/6 inhibitor, given with cetuximab, resulted in an objective response rate (ORR) of 19% in cetuximab-resistant human papillomavirus (HPV)-unrelated head and neck squamous-cell carcin
Autor:
Andrew Thamboo, Annette X. Ye, Sarah Hamilton, Eitan Prisman, David C. Jewett, Joel Howlett, Breanna Riou-Green
Publikováno v:
Oral oncology. 114
Nasopharyngeal carcinoma (NPC) is common in Southeast Asia. Due to the influx of immigrants from this region, the incidence in British Columbia is increasing. Current literature from non-endemic populations encompasses heterogeneous cohorts. This stu
Publikováno v:
Oral oncology. 106
Objectives Transoral approaches for laryngeal/pharyngeal malignancies have been widely accepted as minimally invasive treatment options; however, hypopharyngeal lesions treated by transoral surgery have rarely been reported due to the difficulties in
Publikováno v:
Oral Oncology. 75:100-105
Background and Purpose In 2017, the 8th edition of the nasopharyngeal carcinoma (NPC) staging manual published by the Union for International Cancer Control/American Joint Committee on Cancer (UICC/AJCC) defined new rules regarding the involvement of
Autor:
Li Tian, Li Zhi Liu, Yuan Zhang, Jun Ma, Ying Sun, Ling Long Tang, Xu Liu, Rui Guo, Wen Fei Li
Publikováno v:
Oral Oncology. 75:120-126
Twelve weeks after radiotherapy is the recommended time-point for assessing tumor response in nasopharyngeal carcinoma (NPC); however, regression after 12 weeks remains unclear. We explored NPC regression and the prognosis of patients with delayed cl
Autor:
Bin Zhang, Xiao-Li Qin, Hua-Ying Tang, Da-Cheng Yao, Jin-Fang Fan, Yi-Xin Su, Wei Jiang, Shu-Fang Liao, Yu-Fei Pan, Jing-Lin Mi
Publikováno v:
Oral Oncology. 74:34-39
Objectives The efficacy of various chemotherapy regimens in nasopharyngeal carcinoma (NPC) remains under debate. We compared the efficacy and toxicity of a taxane-based regimen and regimen including fluorouracil in NPC. Materials and methods Eight-hu
Autor:
Roy B. Tishler, Bhupendra Rawal, Laura A. Goguen, Danielle N. Margalit, Robert I. Haddad, Paul J. Catalano, Nicole G. Chau, Jochen H. Lorch, Guilherme Rabinowits, Donald J. Annino, Jonathan D. Schoenfeld
Publikováno v:
Oral Oncology. 73:160-165
Objectives To characterize specific serious toxicities of reRT with intensity modulated radiation therapy (IMRT) for squamous cell carcinoma of the head and neck (SCCHN) and identify treatment-related predictors of toxicity for patient counseling and